Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schein

Showing results (1271-1280 of 1,319) with videos related to

Pageof 132
Sort By:
The Journal of Infectious Diseases|September 1, 1996
Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study GroupS T Donta, P Peduzzi, A S Cross, et al.
Nature Communications|March 13, 2021
Ultrafast multi-cycle terahertz measurements of the electrical conductivity in strongly excited solidsZ Chen, C B Curry, R Zhang, et al.
Cornea|November 15, 2006
Dysfunctional tear syndrome: a Delphi approach to treatment recommendationsAshley Behrens, John J Doyle, Lee Stern, et al.
Nucleic Acids Research|July 13, 2004
A set of BAC clones spanning the human genomeMartin Krzywinski, Ian Bosdet, Duane Smailus, et al.
Journal of Bacteriology|November 2, 2004
Functional characterization of a catabolic plasmid from polychlorinated- biphenyl-degrading Rhodococcus sp. strain RHA1René Warren, William W L Hsiao, Hisashi Kudo, et al.
Nature Methods|October 12, 2010
De novo assembly and analysis of RNA-seq dataGordon Robertson, Jacqueline Schein, Readman Chiu, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancersJanessa Laskin, Steven Jones, Samuel Aparicio, et al.
Oncotarget|April 2, 2016
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancerYinghong Pan, Gordon Robertson, Lykke Pedersen, et al.
JAMA|March 21, 2013
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trialSteven M Opal, Pierre-Francois Laterre, Bruno Francois, et al.
Cancer|July 1, 1978
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group ReportP S Schein, P T Lavin, C G Moertel, et al.
Pageof 132

Showing results (1271-1280 of 1,319) with videos related to

Sort By:
Pageof 132
The Journal of Infectious Diseases|September 1, 1996
Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study GroupS T Donta, P Peduzzi, A S Cross, et al.
Nature Communications|March 13, 2021
Ultrafast multi-cycle terahertz measurements of the electrical conductivity in strongly excited solidsZ Chen, C B Curry, R Zhang, et al.
Cornea|November 15, 2006
Dysfunctional tear syndrome: a Delphi approach to treatment recommendationsAshley Behrens, John J Doyle, Lee Stern, et al.
Nucleic Acids Research|July 13, 2004
A set of BAC clones spanning the human genomeMartin Krzywinski, Ian Bosdet, Duane Smailus, et al.
Journal of Bacteriology|November 2, 2004
Functional characterization of a catabolic plasmid from polychlorinated- biphenyl-degrading Rhodococcus sp. strain RHA1René Warren, William W L Hsiao, Hisashi Kudo, et al.
Nature Methods|October 12, 2010
De novo assembly and analysis of RNA-seq dataGordon Robertson, Jacqueline Schein, Readman Chiu, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancersJanessa Laskin, Steven Jones, Samuel Aparicio, et al.
Oncotarget|April 2, 2016
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancerYinghong Pan, Gordon Robertson, Lykke Pedersen, et al.
JAMA|March 21, 2013
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trialSteven M Opal, Pierre-Francois Laterre, Bruno Francois, et al.
Cancer|July 1, 1978
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group ReportP S Schein, P T Lavin, C G Moertel, et al.
Pageof 132